Immunopharmacology And Immunotoxicology SCIE

国际简称：IMMUNOPHARM IMMUNOT 参考译名：免疫药理学和免疫毒理学

主要研究方向：医学-毒理学非预警期刊审稿周期：偏慢,4-8周

《免疫药理学和免疫毒理学》(Immunopharmacology And Immunotoxicology)是一本由Informa Healthcare出版的以医学-毒理学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q2 JCR分区
59 年发文量
2.9 IF影响因子
未开放 是否OA
42 H-index
1987 创刊年份
Quarterly 出版周期
English 出版语言

The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal.

The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.

With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.

Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).

[ 查看全部 ]

投稿咨询加急咨询

Immunopharmacology And Immunotoxicology期刊信息

ISSN：0892-3973
出版语言：English
是否OA：未开放
E-ISSN：1532-2513
出版地区：UNITED STATES
是否预警：否
出版商：Informa Healthcare
出版周期：Quarterly
创刊时间：1987
开源占比：0.0297
Gold OA文章占比：4.26%
OA被引用占比：0
出版国人文章占比：0.35
出版撤稿占比：0.0136...
研究类文章占比：86.44%

Immunopharmacology And Immunotoxicology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.4

0.68

0.679

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Toxicology	Q2	58 / 133	56%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q2	141 / 313	55%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology and Allergy	Q2	115 / 233	50%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology	Q3	133 / 236	43%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Immunopharmacology And Immunotoxicology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	TOXICOLOGY 毒理学 IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学	3区 4区 4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区 4区 4区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区 4区 4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区 4区 4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区 4区 4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区 4区 4区

Immunopharmacology And Immunotoxicology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q3	108 / 181	40.6%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	147 / 354	58.6%
学科：TOXICOLOGY	SCIE	Q2	49 / 106	54.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q2	85 / 181	53.31%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	162 / 354	54.38%
学科：TOXICOLOGY	SCIE	Q2	53 / 106	50.47%

Immunopharmacology And Immunotoxicology历年数据统计

影响因子

中科院分区

Immunopharmacology And Immunotoxicology中国学者发文选摘

1、Xanthones from securidaca inappendiculata antagonizes the anti-rheumatic effect of methotrexate by inhibiting reduced folate carrier 1
Author: Zhang, Sa-sa; Wu, Yi-jin; Pan, Shu; Wang, Qi-hai; Chen, Wen-gang; Wang, Zhong-fang; Xu, Jin-ying; Zuo, Jian; Yin, Qin

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 16-25. DOI: 10.1080/08923973.2022.2103707
2、A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
Author: Liu, Tong; Jiang, Shuai; Teng, Xue; Zhong, Lu; Liu, Mengmeng; Jin, Yao; Dong, Mei

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 1-9. DOI: 10.1080/08923973.2022.2112222
3、Corynoline ameliorates dextran sulfate sodium-induced colitis in mice by modulating Nrf2/NF-kappa B pathway
Author: Zhang, Haihua; Lang, Wuying; Li, Sufen; Xu, Chao; Wang, Xiumin; Li, Yunyu; Zhang, Zhiqiang; Wu, Tonglei; Feng, Minshan

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 26-34. DOI: 10.1080/08923973.2022.2112218
4、Sulforaphane suppresses skin squamous cell carcinoma cells proliferation through miR-199a-5p/Sirt1/CD44ICD signaling pathway
Author: Zhang, Yang; Ai, Ping; Chen, Shang-zhou; Lei, Shu-ying

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 52-60. DOI: 10.1080/08923973.2022.2112221
5、Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA
Author: Zeng, Chaoxia; Long, Mingxia; Lu, Ying

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 35-42. DOI: 10.1080/08923973.2022.2112219
6、alpha-Cyperone ameliorates depression in mammary gland hyperplasia and chronic unpredictable mild stress rat by regulating hormone, inflammation, and oxidative stress
Author: Qiao, Nan; Wang, Qinnan; Tao, Ye; Wu, Jinna; Fang, Yong; Ni, Yusheng; Ding, Xiaowen

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 73-82. DOI: 10.1080/08923973.2022.2115925
7、Protective effects of Tripterygium glycoside on IL-1 beta-induced inflammation and apoptosis of rat chondrocytes via microRNA-216a-5p/TLR4/NF-kappa B axis
Author: Huang, Zhen; Song, Shuanglin; Zhang, Di; Bian, Zhenyu; Han, Jinsheng

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 61-72. DOI: 10.1080/08923973.2022.2115924
8、Sestrin2 suppresses ferroptosis to alleviate septic intestinal inflammation and barrier dysfunction
Author: Liu, Wei; Xu, Chanchan; Zou, Zhiqiang; Weng, Qinyong; Xiao, Ying

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 2, pp. 123-132. DOI: 10.1080/08923973.2022.2121927